Clinical Trial Update: A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. [Phase 1]

View source ↗

Summary

Phase 1 study assessing how radiolabeled E7080 (lenvatinib) is metabolized and eliminated in patients with advanced solid tumors or lymphoma; the trial has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: Eisai Inc. | Conditions: Advanced Solid Tumors, Lymphomas | Phase 1 | Status: COMPLETED | Results posted: 2017-06-20